【正文】 如事先知道該雜志有興趣再出版該評價(jià)的 COCHRANE 版本，則評價(jià)者不能授予該雜志獨(dú)有出版權(quán)（見 章）。） Occasionally a Cochrane Review will be similar enough to a previously published review that the only change is in the formatting of the review. In these cases reviewers should obtain permission from the publisher of the previously published review prior to publishing the review in CDSR. If reviewers are in doubt about whether they should request permission, they are encouraged to do so. This is unlikely to present a problem, provided it is done well in advance of the planned submission to CDSR. If it is known in advance that there is interest in publishing a version of a Cochrane Review in a journal, reviewers should not assign exclusive copyright to the journal (see section ). The Cochrane Collaboration does not require exclusive copyright. It is therefore not a problem to publish a version of a Cochrane Review in a journal after it has been published in CDSR, provided it is not called a Cochrane Review and that it is acknowledged that it is based on a Cochrane Review (see section ). 該綜述可以和原文章相似，只是在格式上 有差別。） Publication of previously published reviews as Cochrane Reviews 以前發(fā)表的綜述（已發(fā)表系統(tǒng)評價(jià)如何成為 COCHRANE 系統(tǒng)評價(jià)） Most reviews that have been previously published (referred to as 39。該組織無權(quán)侵犯其他雜志的版權(quán)。另外，在雜志上發(fā)表 COCHRANE 系統(tǒng)評價(jià)時(shí)，應(yīng)將 COCHRANE Library 的不承擔(dān)責(zé)任的聲明稍做修改并在文章中附上：“鑒于不同人群的觀念和實(shí)際情況的差異， COCHRANE 系統(tǒng)評價(jià)的結(jié)果可以有不同的解釋，故請慎用文中結(jié)論，其僅代表評價(jià)作者觀點(diǎn)，并不一定代表 COCHRANE 協(xié)作網(wǎng)觀點(diǎn)。參考”，參考部分代表 CDSR 上發(fā)表評價(jià)的草案?？梢栽诓挥绊懺獾幕A(chǔ)上選擇性的縮短綜述。 （我們強(qiáng)烈反對評價(jià)者早于 CDSR 在雜志發(fā)表他們的系統(tǒng)評價(jià)，尤其是 COCHRANE 中心主任及評價(jià)協(xié)作組的編輯應(yīng)該注意。 （ COCHRANE 評價(jià)者可能希望尋求有同行審稿的醫(yī)學(xué)雜志共同出版 COCHRANE 系統(tǒng)評價(jià)，尤其是對共同發(fā)表 COCHRANE 系統(tǒng) 評價(jià)表現(xiàn)了極高熱情的雜志。即使評價(jià)者堅(jiān)信自己的判斷力不會受影響，也應(yīng)讓 CRG 的編輯們知曉潛在的沖突。（ Smith 1994) 經(jīng)濟(jì)利益沖突最受 人關(guān)注，是能夠并應(yīng)該避免的，一旦存在，則必須在報(bào)告中予以透露。） Conflict of interest statements in reviews 綜述中提及的利益沖突（利益沖突聲明） Under the heading 39。 COCHRANE 協(xié)作網(wǎng)規(guī)定，不接受可能對評價(jià)結(jié)果造成利益導(dǎo)向的單方面資金贊助。 表格和圖形－顯示納入研究的特征，比較的干預(yù)措施的明細(xì)，納入研究的結(jié)果，排除研究的記錄，有關(guān)評價(jià)的額外圖表（和評價(jià)相關(guān)的附加圖形 ） 參考內(nèi)容 Standard headings and tables guide reviewers when preparing their report and make it easier for readers to identify information that is of particular interest to them. The headings are listed below. The content that should follow each heading and the elements that will be published are described in appendix 2a (Guide to the format of a Cochrane Review). 標(biāo)準(zhǔn)化的標(biāo)題和表格知道評價(jià)者在準(zhǔn)備他們的報(bào)告時(shí)使他們的報(bào)告更容易讓讀者辨別出他們感興趣的信息。目前我們付出巨大的努力來改善系統(tǒng)評價(jià)數(shù)據(jù)庫（ CDSR），此格式一定可以被很好的定義并固定下來。首先它能幫助讀者快速的找到研究結(jié)果，評價(jià)真實(shí)性、適用性和那些結(jié)果的含義。（ COCHRANE 評價(jià)的最初格式是由 Mike Clarke, Murray Enkin, Chris Silagy, Mark Starr 及其同行們共同設(shè)計(jì)的。 （根據(jù)于評價(jià)協(xié)作組的經(jīng)驗(yàn)，系統(tǒng)評價(jià)用戶的反饋及系統(tǒng)評價(jià)管理軟件（ RevMan）顧問組（用于撰寫 系統(tǒng)評價(jià)的軟件 Revman 的規(guī)范即是他們制定的）的建議，我們對 94 年第一版格式做了少量修改。） Outline of a Cochrane Review Cover sheet: Title Reviewers Sources of support What’s New Text of review: Synopsis Abstract Background Objectives Search strategy Selection criteria Data collection amp。 （以下告誡 /建議來源于 COCHRANE 協(xié)作網(wǎng)指導(dǎo)法規(guī)，關(guān)于避免潛在的經(jīng)濟(jì)利益沖突（見附錄 2b） 如收到研究贊助單位的好處，須在 CDSR 及其他協(xié)作網(wǎng)發(fā)行的出版物中承認(rèn)并透露利益沖突。一些可能影響判斷力的次級沖突也應(yīng)該被提出來 (例如研究的相容性和排斥性，評價(jià)研究或者譯文的有效性 )。編輯人員有責(zé)任讓讀者了解利益沖突以便引起足夠的重視，是否公開這一信息則是由評論者和編輯人員決定。） Publication of Cochrane Reviews in print journals and books 雜志或者圖書中出版的綜述（以雜志和書籍形式出版 COCHRANE 系統(tǒng)評價(jià)） Reviewers may wish to seek copublication of Cochrane Reviews in peerreviewed medical journals, particularly in those journals that have expressed enthusiasm for copublication of Cochrane Reviews. For the Cochrane Collaboration, there is one essential condition of copublication: Cochrane Reviews must remain free for dissemination in any and all media, without restriction from any of them. To ensure this, Cochrane reviewers grant the Collaboration worldwide licences for these activities, and do not sign over exclusive copyright to any journal or other publisher. A journal is free to request a nonexclusive copyright that permits it to publish and republish a review, but this cannot restrict the publication of the review by the Cochrane Collaboration in whatever form the Collaboration feels appropriate. 評論者熱衷于尋找醫(yī)學(xué)雜志中特別是那些向 cochrane 綜述表示合作意向的雜志。這種情況將直接上報(bào)中心主任，然而一些雜志可能會堅(jiān)持說 CDSR 上的文章并不是在他們之前發(fā)表的。） J